FilingSEC EDGAR6-K
NeuroSense Therapeutics Shareholders Approve Reverse Split Authority
· SEC accepted
StageShareholder Approval
Filing content
Shareholders approved authorizing the Board to effect a reverse share split at a ratio between 1-for-4 and 1-for-40 within 12 months.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…